Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9240815PMC
http://dx.doi.org/10.1016/j.jiph.2022.05.001DOI Listing

Publication Analysis

Top Keywords

retraction notice
4
notice "antiviral
4
"antiviral treatment
4
treatment provide
4
provide clinical
4
clinical benefit
4
benefit management
4
management mild
4
mild covid-19
4
covid-19 retrospective
4

Similar Publications

[Retracted] Inhibition of neddylation modification by MLN4924 sensitizes hepatocellular carcinoma cells to sorafenib.

Oncol Rep

March 2025

Key Laboratory of Hepatobiliary and Pancreatic Surgery, Institute of Hepatobiliary Surgery, Southwest Hospital, Third Military Medical University (Army Medical University), Shapingba, Chongqing 400038, P.R. China.

Following the publication of the above article, the authors noticed that they had inadvertently included a duplication of the same data in Fig. 3C, portraying colony formation experiments, where the results from differently performed experiments were intended to have been shown, and requested that a corrigendum be published to present the data in this figure accurately. Having investigated this matter in the Editorial Office, however, additional panels of overlapping data were identified, comparing between Figs.

View Article and Find Full Text PDF

This article has been retracted: please see Elsevier Policy on Article Withdrawal (https://www.elsevier.com/locate/withdrawalpolicy).

View Article and Find Full Text PDF

This article has been retracted: please see Elsevier Policy on Article Withdrawal (https://www.elsevier.com/locate/withdrawalpolicy).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!